The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership with leading Ad-tech tech provider

30 Sep 2020 08:30

RNS Number : 4966A
Iconic Labs PLC
30 September 2020
 

 

 

 

 

Iconic Labs Plc ("Iconic Labs" or the "Company")

 

Partnership with leading Ad-tech tech provider

 

Iconic Labs Plc (LSE:ICON), a multidivisional new media and technology business, today announces that after a successful trial Iconic Labs has signed a commercial partnership agreement with Glimpse Protocol, a leading provider of advanced technologies to Ad-tech.

This partnership will allow Iconic Labs to be well positioned to become industry leaders in the cookieless advertising space and future proof this part of the Company's business. Glimpse Protocol will benefit from Iconic Labs advertising experience and access to multiple platforms, including to trial their technology.

Glimpse Protocol will compete for programmatic inventory on the Iconic Labs platforms with other advertisers and will not receive any discount to market rate. This offering will allow programmatic advertisers to comply with GDPR and internal policies while still conducting effective advertising.

Iconic Labs will use the Glimpse Protocol's technology on all of their owned and operated platforms including JOE Media where the Glimpse Protocol platform will be tested and monitored in real time. The Glimpse Protocol platform is currently live on TLE, protecting 1.5million readers so far from their browsing information being obtained by other parties.

In addition to the operational benefits that it provides, it has been agreed that warrants will be issued to Iconic Labs in recognition of their market access and wider advisory support. The warrants entitle Iconic Labs to subscribe for such number of ordinary shares in the capital of Glimpse Protocol, which shall be equal to 1.25% of its issued equity and which are exercisable at a discount to the subscription price payable for ordinary shares on any future sale or capital raise undertaken by Glimpse Protocol.

Glimpse Protocol are a market leader in data protection using frontier technologies. Their cookieless platform uses two forms of advanced cryptography to protect consumers' personal internet browsing data from being seen, read, transferred, sold or recycled by another party.

Google have recently announced within 2 years their chrome browser will no longer be using cookies which store personal browsing data on your PC/Phone. Apple have also taken a similar approach with their safari browser.

Samuel Regan Asante COO of Iconic Labs - "We are very pleased to announce a partnership with Glimpse Protocol who are leading the way in cookie-less technologies within the AdTech industry. Iconic Labs is aiming to establish itself as a leader in both the tech and media fields and Glimpse Protocol's technology presents the perfect balance of the two. With Glimpse Protocol's existing partnership with The Founder's Factory we're excited about their future as a leader in the industry."

 

 

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Iconic Labs ir@iconiclabs.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRUKONRROUKUAR
Date   Source Headline
5th Mar 201911:00 amRNSPrice Monitoring Extension
28th Feb 20192:20 pmRNSHolding(s) in Company
26th Feb 20195:44 pmRNSHolding(s) in Company
25th Feb 20198:12 amRNSDirectorate Change
22nd Feb 20195:50 pmRNSPublication of Prospectus
20th Feb 20194:06 pmRNSHolding(s) in Company
1st Feb 201912:35 pmRNSHolding(s) in Company
24th Jan 20193:37 pmRNSHolding(s) in Company
15th Jan 201911:14 amRNSHolding(s) in Company
11th Jan 201912:23 pmRNSHolding(s) in Company
10th Jan 201911:19 amRNSHolding(s) in Company
9th Jan 201912:06 pmRNSHolding(s) in Company
15th Nov 20181:03 pmRNSGM Results
14th Nov 20186:07 pmRNSHolding(s) in Company
6th Nov 20182:18 pmRNSIssue and Allotment of Ordinary Shares
31st Oct 20187:00 amRNS3rd Conversion of Bond
30th Oct 20186:10 pmRNSReplacement - Notice of General Meeting
30th Oct 20184:25 pmRNSNotice of AGM
30th Oct 20182:05 pmRNSSecond Price Monitoring Extn
30th Oct 20182:00 pmRNSPrice Monitoring Extension
30th Oct 20187:00 amRNSWideacademy Restructuring
29th Oct 20184:33 pmRNSHolding(s) in Company
23rd Oct 20188:27 amRNSConversion of Bond
22nd Oct 20183:27 pmRNSConversion of bonds
22nd Oct 20187:00 amRNSSmart Cells Deal
19th Oct 20189:20 amRNSHolding(s) in Company
18th Oct 201812:47 pmRNSBoard Restructuring
17th Oct 20184:48 pmRNSHolding(s) in Company
1st Oct 201811:00 amRNSPrice Monitoring Extension
28th Sep 20183:30 pmRNSHolding(s) in Company
27th Sep 20184:40 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
27th Sep 201810:40 amRNSNotification of transactions of Directors
27th Sep 20187:10 amRNSInterim Results
27th Sep 20187:00 amRNSFinancing Agreement
30th Jul 20187:00 amRNSCellPlan Launch in Spain
9th Jul 20187:01 amRNSBoard Changes
9th Jul 20187:00 amRNSHolding(s) in Company
29th Jun 20183:00 pmRNSResult of AGM
28th Jun 201810:30 amRNSResult of General Meeting
15th Jun 20187:00 amRNSAlign Research Initiation of Coverage
12th Jun 20186:25 pmRNSProspectus and Notice of General Meeting
11th Jun 20189:00 amRNSLive Market Bookbuild Closes
11th Jun 20187:30 amRNSRestoration Widecells Group Plc
11th Jun 20187:00 amRNSUpdate Regarding Placing and Financial Position
6th Jun 20183:00 pmRNSNotice of AGM
5th Jun 20187:00 amRNSAudited Preliminary Results
21st May 20187:00 amRNSFinal Results Update
10th May 201810:30 amRNSPlacing to Raise £1.47m and Live Market Bookbuild
3rd May 20187:30 amRNSSuspension Widecells Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.